On the effects of DMAE (2-dimetbylaminoethanol) upon chronic schizophrenics

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Seventy five mg of DMAE (2-dimethylaminoethanol) was daily administered per os for two months in succession to 7 chronic and deteriorated schizophrenics who had been treated with specific psychiatric therapies and at present so-called schizophrenic dementia. Disturbance of volition shuch as apathy, mutism and motionlessness in bed was remarkably improved. Among 7 cases, 3 were apparently found to be effective, 2 were fairly and 2 were not so effective. Severe insomnia and neurological side-effects were not observed. DMAE (2-dimethylaminoethanol) can be applied to withdraw schizophrenic patients according to motivate the volition for play or work-therapy and to mitigate cares on nursing and ward-management. © 1960, Japanese Society of National Medical Services. All rights reserved.

Cite

CITATION STYLE

APA

Seino, M., Ishida, M., Ishikawa, S., & Tsukahara, S. (1960). On the effects of DMAE (2-dimetbylaminoethanol) upon chronic schizophrenics. Japanese Journal of National Medical Services, 14(4), 335–338. https://doi.org/10.11261/iryo1946.14.335

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free